Innovative Northern Irish technology benefits dairy industry
Randox Food Diagnostics in Northern Ireland has developed a unique testing solution specifically tailored to suit the needs of the dairy industry for greater safety from antibiotic and pesticide residues.
The company, a subsidiary of Randox, a global leader in diagnostic technologies, has developed InfiniPlex for Milk Array that uses patented Biochip Array Technology to provide the dairy industry fast, efficient results with enhanced supplier traceability.
The technology enables users to become 98 percent compliant with EU antibiotic regulations in one single sample, and screening for further potential substances making it the most comprehensive testing system available.
The unique diagnostic system provides a single test and analysis that otherwise would require 39 existing kits that still only achieve 77 percent compliance with EU regulated antibiotics.
Biochip Array Technology is an innovative screening platform that provides multiple test results from a single, undivided sample saving both time and money compared to other screening methods.
The unique testing method uses a tiny ceramic chip to deliver accurate, trusted results and is particularly suited to the dairy industry with the ability to simultaneously detect antibiotic residues, anti-parasitic residues, unauthorised substances and pathogens in milk from a single unprepared sample.
The leading-edge technology provides users with a screening method that requires zero time to prepare samples meaning that minimal time is added to the production process.The array also provides drug discrimination capabilities as detected residues are often unique combinations of pharmaceutical products. Infiniplex can detect the individual compounds of veterinary drugs used to provide a deeper insight into the group of drugs being administered at animal level.
Based in Antrim, Randox Food Diagnostics has extensive experience in drug residue kits, wine testing kits and analysers worldwide. It builds on the experience of Random in the development of diagnostic kits over 30 years.